Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shamir R Mehta

Showing results (31-40 of 212) with videos related to

Pageof 22
Sort By:
Circulation. Cardiovascular Interventions|April 16, 2015
Activated clotting time and outcomes during percutaneous coronary intervention for non-ST-segment-elevation myocardial infarction: insights from the FUTURA/OASIS-8 TrialGregory Ducrocq, Sanjit Jolly, Shamir R Mehta, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 21, 2007
Renal function and outcomes in acute coronary syndrome: impact of clopidogrelMátyás Keltai, Marcello Tonelli, Johannes F E Mann, et al.
European Heart Journal|June 1, 2011
Implications of variability in definition and reporting of major bleeding in randomized trials of oral P2Y12 inhibitors for acute coronary syndromesDaniel J Quinlan, John W Eikelboom, Shaun G Goodman, et al.
Circulation|December 2, 2009
Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarctionAbhinav Goyal, Shamir R Mehta, Rafael Díaz, et al.
American Heart Journal|June 22, 2015
Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trialKevin R Bainey, Sherali Rahim, Krystal Etherington, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 15, 2020
Safety and efficacy of the bioabsorbable polymer everolimus-eluting stent versus durable polymer drug-eluting stents in high-risk patients undergoing PCI: TWILIGHT-SYNERGYUsman Baber, Rishi Chandiramani, Shamir R Mehta, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 18, 2021
First in-human evaluation of a novel intravascular ultrasound and optical coherence tomography system for intracoronary imagingElie Akl, Natalia Pinilla-Echeverri, Hector M Garcia-Garcia, et al.
European Heart Journal|February 10, 2009
Early invasive compared with a selective invasive strategy in women with non-ST-elevation acute coronary syndromes: a substudy of the OASIS 5 trial and a meta-analysis of previous randomized trialsEva Swahn, Joakim Alfredsson, Rizwan Afzal, et al.
American Heart Journal|April 29, 2008
Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor useMarc S Sabatine, Hussam N Hamdalla, Shamir R Mehta, et al.
Circulation. Cardiovascular Genetics|February 28, 2012
Effect of PON1 Q192R genetic polymorphism on clopidogrel efficacy and cardiovascular events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events trial and the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular EventsGuillaume Paré, Stephanie Ross, Shamir R Mehta, et al.
Pageof 22

Showing results (31-40 of 212) with videos related to

Sort By:
Pageof 22
Circulation. Cardiovascular Interventions|April 16, 2015
Activated clotting time and outcomes during percutaneous coronary intervention for non-ST-segment-elevation myocardial infarction: insights from the FUTURA/OASIS-8 TrialGregory Ducrocq, Sanjit Jolly, Shamir R Mehta, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 21, 2007
Renal function and outcomes in acute coronary syndrome: impact of clopidogrelMátyás Keltai, Marcello Tonelli, Johannes F E Mann, et al.
European Heart Journal|June 1, 2011
Implications of variability in definition and reporting of major bleeding in randomized trials of oral P2Y12 inhibitors for acute coronary syndromesDaniel J Quinlan, John W Eikelboom, Shaun G Goodman, et al.
Circulation|December 2, 2009
Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarctionAbhinav Goyal, Shamir R Mehta, Rafael Díaz, et al.
American Heart Journal|June 22, 2015
Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trialKevin R Bainey, Sherali Rahim, Krystal Etherington, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 15, 2020
Safety and efficacy of the bioabsorbable polymer everolimus-eluting stent versus durable polymer drug-eluting stents in high-risk patients undergoing PCI: TWILIGHT-SYNERGYUsman Baber, Rishi Chandiramani, Shamir R Mehta, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 18, 2021
First in-human evaluation of a novel intravascular ultrasound and optical coherence tomography system for intracoronary imagingElie Akl, Natalia Pinilla-Echeverri, Hector M Garcia-Garcia, et al.
European Heart Journal|February 10, 2009
Early invasive compared with a selective invasive strategy in women with non-ST-elevation acute coronary syndromes: a substudy of the OASIS 5 trial and a meta-analysis of previous randomized trialsEva Swahn, Joakim Alfredsson, Rizwan Afzal, et al.
American Heart Journal|April 29, 2008
Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor useMarc S Sabatine, Hussam N Hamdalla, Shamir R Mehta, et al.
Circulation. Cardiovascular Genetics|February 28, 2012
Effect of PON1 Q192R genetic polymorphism on clopidogrel efficacy and cardiovascular events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events trial and the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular EventsGuillaume Paré, Stephanie Ross, Shamir R Mehta, et al.
Pageof 22